AstraZeneca AI case studies

Explore 3 documented AI medicine implementations at AstraZeneca. These source-extracted records passed the automated evidence gate; that is not independent fact verification.

Pharmaceutical & Life Science · Enterprise · 3 AI implementations

AstraZeneca has 3 documented AI medicine implementations covering workflows including Drug Discovery & Development and technology including Machine Learning & Predictive Analytics, Large Language Models & Generative AI. The records below separate source-reported results from evidence the source did not provide.

Based on 3 documented implementationsCorpus published through Mar 28, 2026Source links checked through Jul 28, 2026

Maintained by Peter Korpak, Founder & Chief AnalystHow evidence is checked

Case Studies

Use Case Types

Technologies

AI implementations at AstraZeneca

AstraZeneca

AstraZeneca uses BostonGene AI foundation model to predict patient safety and efficacy in early oncology trials

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics

Reported result:: Not reported by source
Deployment timeframe:: Not reported by source
Technology:: Machine Learning & Predictive Analytics
Vendor:: Not available in record

Cited source: www.appliedclinicaltrialsonline.comSource link checked Jul 28, 2026Automated evidence gate passed

AstraZeneca

AstraZeneca's MILTON AI Predicts 1,091 Diseases Before Diagnosis Using UK Biobank Genomic Data

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentMachine Learning & Predictive Analytics

Reported result:: 1,091 Diseases Predicted at High Accuracy (AUC > 0.7)
Deployment timeframe:: Not reported by source
Technology:: Machine Learning & Predictive Analytics
Vendor:: Not available in record

Cited source: www.sandeepanand.inSource link checked Jul 28, 2026Automated evidence gate passed

AstraZeneca

AstraZeneca cuts protocol authoring time 85% with Modella AI multimodal models in oncology R&D

Pharmaceutical & Life ScienceDrug Discovery & DevelopmentLarge Language Models & Generative AI

Reported result:: 85% Protocol Authoring Time Reduction
Deployment timeframe:: Not reported by source
Technology:: Large Language Models & Generative AI
Vendor:: Not available in record

Cited source: www.ainvest.comSource link checked Jul 28, 2026Automated evidence gate passed

More in Pharmaceutical & Life Science

Bristol Myers Squibb5 Insilico Medicine5 Pfizer3 Relay Therapeutics1 Merck & Co.1 Sumitomo Dainippon Pharma1 Leading Global Biopharma Company1 Sanofi1 Bayer1 Merck1